These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2984988

  • 1. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK, Gupta SV, Babiuk LA.
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
    Ayisi NK, Gupta VS, Meldrum JB, Taneja AK, Babiuk LA.
    Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
    Ayisi NK, Meldrum JB, Stuart AL, Gupta VS.
    Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
    [Abstract] [Full Text] [Related]

  • 4. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF, Nahmias AJ.
    Am J Med; 1982 Jul 20; 73(1A):40-8. PubMed ID: 6285731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
    Burkhardt U, Wigand R.
    J Med Virol; 1983 Jul 20; 12(2):137-47. PubMed ID: 6194252
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Meldrum JB, Gupta VS, Babiuk LA.
    Chemotherapy; 1980 Jul 20; 26(1):54-63. PubMed ID: 7353440
    [Abstract] [Full Text] [Related]

  • 8. Anti-herpes virus combinations in relation to drug resistance.
    Hall MJ.
    J Antimicrob Chemother; 1986 Oct 20; 18 Suppl B():165-76. PubMed ID: 3025155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B, Vahlne A, Lycke E.
    Arch Virol; 1981 Oct 20; 69(1):43-8. PubMed ID: 6271097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
    Schinazi RF, Scott RT, Peters J, Rice V, Nahmias AJ.
    Antimicrob Agents Chemother; 1985 Oct 20; 28(4):552-60. PubMed ID: 3000291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.